✦ LIBER ✦

The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer

✍ Scribed by Jean-Marc Ferrero; Emmanuel Chamorey; Nicolas Magné; Frédéric Leccia; Rémy Largillier; Moïse Namer; Gérard Milano

Publisher: Springer
Year: 2002
Tongue: English
Weight: 203 KB
Volume: 50
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-002-0519-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I pharmacodynamic trial of borte

A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer

✍ Noelle K. LoConte; James P. Thomas; Dona Alberti; Jennifer Heideman; Kimberly Bi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 326 KB

Gemcitabine and vinorelbine in patients

Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial

✍ Roy S. Herbst; Cathleen Lynch; Michael Vasconcelles; Beverly A. Teicher; Gary St 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 129 KB

Biomarker-based phase I dose-escalation,

Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer

✍ Karen Reckamp; Barbara Gitlitz; Lin-Chi Chen; Ravi Patel; Ginger Milne; Mary Syt 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Phase II and pharmacokinetic/pharmacodyn

Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer

✍ Afshin Dowlati; Nathan Levitan; Nahida H. Gordon; Charles L. Hoppel; David M. Go 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 125 KB

Sequential vinorelbine–capecitabine foll

Sequential vinorelbine–capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial

✍ Marwan Ghosn; Joseph Kattan; Fadi Farhat; Fariha Younes; Fadi Nasr; Walid Moukad 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 307 KB

A phase I trial of celecoxib in combinat

A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer

✍ Grace K. Dy; Sumithra Mandrekar; Prema P. Peethambaram; Scott H. Okuno; Gary C. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 243 KB